122 related articles for article (PubMed ID: 21474)
21. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
[TBL] [Abstract][Full Text] [Related]
22. Sorption and desorption of three endocrine disrupters in soils.
Hildebrand C; Londry KL; Farenhorst A
J Environ Sci Health B; 2006; 41(6):907-21. PubMed ID: 16893779
[TBL] [Abstract][Full Text] [Related]
23. Irreversible binding of ethynylestradiol metabolites to protein: lack of methylation by S-adenosyl-methionine.
Kappus H; Bolt HM
Horm Metab Res; 1974 Jul; 6(4):333-4. PubMed ID: 4153385
[No Abstract] [Full Text] [Related]
24. Effect of dietary 2(3)-tert-butyl-4-hydroxyanisole on the metabolism and action of estradiol and estrone in female CD-1 mice.
Zhu BT; Lech J; Rosen RT; Conney AH
Cancer Res; 1997 Jun; 57(12):2419-27. PubMed ID: 9192820
[TBL] [Abstract][Full Text] [Related]
25. Influence of alpha-naphthoflavone on the metabolism and binding of ethinylestradiol in male Syrian hamster liver microsomes: possible role in hepatocarcinogenesis.
Haaf H; Metzler M; Li JJ
Cancer Res; 1988 Oct; 48(19):5460-5. PubMed ID: 3416302
[TBL] [Abstract][Full Text] [Related]
26. Placental transfer and metabolism of 17 alpha-ethynylestradiol-17 beta and estradiol-17 beta in the rhesus monkey.
Slikker W; Bailey JR; Newport D; Lipe GW; Hill DE
J Pharmacol Exp Ther; 1982 Nov; 223(2):483-9. PubMed ID: 7131302
[TBL] [Abstract][Full Text] [Related]
27. Irreversible binding and metabolism of propranolol by human liver microsomes--relationship to polymorphic oxidation.
Shaw L; Lennard MS; Tucker GT; Bax ND; Woods HF
Biochem Pharmacol; 1987 Jul; 36(14):2283-8. PubMed ID: 3111480
[TBL] [Abstract][Full Text] [Related]
28. Drug protein conjugates--III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed-function oxidase inhibitors, ascorbic acid and thiols.
Maggs JL; Grabowski PS; Park BK
J Steroid Biochem; 1983 Sep; 19(3):1273-8. PubMed ID: 6621036
[TBL] [Abstract][Full Text] [Related]
29. Microbial degradation of 17beta -estradiol and 17alpha -ethinylestradiol followed by a validated HPLC-DAD method.
Ribeiro AR; Carvalho MF; Afonso CM; Tiritan ME; Castro PM
J Environ Sci Health B; 2010 May; 45(4):265-73. PubMed ID: 20390962
[TBL] [Abstract][Full Text] [Related]
30. Irreversible protein binding of metabolites of ethynylestradiol in vivo and in vitro.
Kappus H; Bolt HM; Remmer H
Steroids; 1973 Aug; 22(2):203-25. PubMed ID: 4147486
[No Abstract] [Full Text] [Related]
31. Role of rat cytochromes P450 in the oxidation of 17α-ethinylestradiol.
Bořek-Dohalská L; Valášková P; Černá V; Stiborová M
Environ Toxicol Pharmacol; 2014 Nov; 38(3):852-60. PubMed ID: 25461545
[TBL] [Abstract][Full Text] [Related]
32. Effect of polybrominated biphenyls on hepatic microsomal metabolism of estrogens and uterotropic action of administered estrogen in rats.
Bonhaus DW; McCormack KM; Braselton WE; Hook JB
J Toxicol Environ Health; 1981; 8(1-2):141-50. PubMed ID: 6276575
[TBL] [Abstract][Full Text] [Related]
33. Effect of rifampicin treatment on the metabolism of oestradiol and 17alpha-ethinyloestradiol by human liver microsomes.
Bolt HM; Kappus H; Bolt M
Eur J Clin Pharmacol; 1975 Jun; 8(5):301-7. PubMed ID: 1233229
[TBL] [Abstract][Full Text] [Related]
34. Effects of insecticide synergists on microsomal oxidation of estradiol and ethynylestradiol and on microsomal drug metabolism.
Bolt HM; Kassel H
Xenobiotica; 1976 Jan; 6(1):33-8. PubMed ID: 1274368
[TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon.
Newburger J; Castracane VD; Moore PH; Williams MC; Goldzieher JW
Am J Obstet Gynecol; 1983 May; 146(1):80-7. PubMed ID: 6846427
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5.
Lee AJ; Kosh JW; Conney AH; Zhu BT
J Pharmacol Exp Ther; 2001 Aug; 298(2):420-32. PubMed ID: 11454902
[TBL] [Abstract][Full Text] [Related]
37. Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations.
Miller KJ; Anderholm DC; Ames MM
Biochem Pharmacol; 1986 May; 35(10):1737-42. PubMed ID: 3707603
[TBL] [Abstract][Full Text] [Related]
38. The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.
Purba HS; Maggs JL; Orme ML; Back DJ; Park BK
Br J Clin Pharmacol; 1987 Apr; 23(4):447-53. PubMed ID: 3555579
[TBL] [Abstract][Full Text] [Related]
39. Continuous biodegradation of 17beta-estradiol and 17alpha-ethynylestradiol by Trametes versicolor.
Blánquez P; Guieysse B
J Hazard Mater; 2008 Jan; 150(2):459-62. PubMed ID: 17996366
[TBL] [Abstract][Full Text] [Related]
40. Human urinary and liver conjugates of 17alpha-ethnylestradiol.
Helton ED; Williams MC; Goldzieher JW
Steroids; 1976 Jun; 27(6):851-67. PubMed ID: 941195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]